Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human)
LOE Approachingvon willebrand factor/coagulation factor viii complex (human)
BLAINTRAVENOUSPOWDER, FOR SOLUTION
Approved
Dec 2009
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 13h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Wilate is a human-derived von Willebrand Factor/Factor VIII complex administered intravenously as a lyophilized powder for reconstitution. It is indicated for the treatment and management of von Willebrand disease and hemophilia A by replacing deficient or dysfunctional von Willebrand Factor and coagulation Factor VIII. The product restores hemostatic function in patients with inherited bleeding disorders.
LOE Approaching
As LOE approaches, brand teams face declining exclusivity and increased generic/biosimilar competition, signaling possible headcount rationalization or transition to lifecycle management roles.
Mechanism of Action
Pharmacologic Class:
Blood Coagulation Factors
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Wilate offers experience in specialty hematology/bleeding disorder management and hospital-based IV product commercialization, but career growth is constrained by LOE proximity and limited clinical expansion. This is a mature product best suited for professionals seeking stability in established markets or portfolio management experience before transitioning to growth-stage biologics.
Brand Manager
Worked on Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human) at Octapharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.